H.R. 4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021
CBO Score
$72 million
Documentation
Date of Report
Mon October 25th, 2021
CBO Report Details
Legislation Details
117th Congress
To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.
Sponsor: Rep. Frank Pallone — D — NJ
Directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production inv...
JOIN US!
Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.
Lost your Password?
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×